Cardiac surgery volume projections: CABG to decline 3% over next five years

Dana Pfenninger Khan on August 2, 2012  |  Permalink

Topics: Cardiac Surgery, Cardiovascular, Service Lines, Market Assessment, Planning, Strategy, Service Line Growth, Volume Growth

We've recently received numerous requests from our membership looking for information on anticipated trends for CABG and valve procedures. 

Read on to learn more our current forecasts for these procedures, as well as some insights on the productivity and practice portfolio of today’s cardiac surgeons.

Continue reading:
Cardiac surgery volume projections: CABG to decline 3% over next five years

Novel Peripheral DES Passes Key FDA Test

Brian Maher on October 19, 2011  |  Permalink

Topics: Vascular, Cardiovascular, Service Lines, Outcomes, Quality, Performance Improvement, Market Trends, Strategy, Technology Assessment, Planning, Market Assessment

Late last week, the federal Food and Drug Administration’s (FDA’s) Circulatory System Devices panel voted unanimously to recommend approval of Cook Medical’s Zilver PTX drug-eluting stent (DES).  If approved, the Zilver PTX would become the first DES available in the U.S. for the treatment of peripheral arterial disease (PAD) in the superficial femoral artery.

Continue reading:
Novel Peripheral DES Passes Key FDA Test